Table 2 Most common adverse events considered associated with treatment occurring in ≥3% of either treatment group*
Placebo (n = 85) Incidence, n (%) | Pregabalin (n = 82) Incidence, n (%) | |
|---|---|---|
Peripheral edema | 27 (31.8) | 30 (36.6) |
Dizziness | 5 (5.9) | 27 (32.9) |
Weight gain | 1 (1.2) | 12 (14.6) |
Somnolence | 5 (5.9) | 11 (13.4) |
Asthenia | 1 (1.2) | 8 (9.8) |
Ataxia | 0 | 4 (4.9) |
Dry mouth | 1 (1.2) | 4 (4.9) |
Abdomen enlarged | 4 (4.7) | 3 (3.7) |
Edema | 0 | 3 (3.7) |
Euphoria | 0 | 3 (3.7) |
Thinking abnormal | 0 | 3 (3.7) |